Fracture risk appears higher among men taking testosterone treatment for hypogonadism. Testosterone treatment in middle-aged and older men with hypogonadism does not appear to reduce the risk for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Historically, the screening for hypogonadism and ...

SAN FRANCISCO — Adherence to diagnostic and treatment guidelines for male hypogonadism is quite low, with significant differences among medical specialists, a new study found. Off-label use of ...

Please provide your email address to receive an email when new articles are posted on . The proportion of men who reported benefits 5 years after the T4DM trial was similar in the testosterone and ...

Antiangiogenic drugs, crizotinib, and ICIs were associated with the development of hypogonadism in high-risk men who were treated for cancer. Hypogonadism and its management have an impact on symptom ...

Paresh Dandona, MD, PhD, has been honored with a Lifetime Achievement Award from the Androgen Society for recognition of his continuing and progressive contributions to the study of hypogonadotropic ...

Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today announced that Health Canada has approved KYZATREX ® ...

Over a mean follow-up of 33 months, those who used topical 1.62% testosterone gel had a 0.19% incidence of high-grade prostate cancer (Gleason score ≥4 + 3), similar to the 0.12% among placebo-treated ...

CHICAGO — A substantial percentage of testicular cancer survivors have low testosterone levels, which in turn puts them at risk for a plethora of chronic health conditions, including hypertension, ...

Children born prematurely have a higher risk of cognitive and sensory disorders, but also infertility in adulthood. In a new study, a team of researchers from Inserm, University Hospital Lille and ...